Reckitt Benckiser

Public consensus   -   Last updated 24/10/18

Contributors

  • 17 FY18 based on
  • 17 Q3 FY18 based on
  • 14 P9 YTD FY18 based on
  • 17 FY19 based on
Reporting currency: GBP
Reporting unit: Millions
FY18
CONSENSUS
24/10/18
Q3 FY18
CONSENSUS
24/10/18
P9 YTD FY18
CONSENSUS
24/10/18
FY19
CONSENSUS
24/10/18
Reckitt Benckiser Group Plc
Net Revenue Growth: Like for Like
IFCN
5.1
5.3
5.5
4.4
Rest of Health
2.5
3.8
2.7
4.0
Total Health
3.1
4.4
3.1
4.1
Hygiene Home
3.3
3.4
3.7
2.9
Group growth: like-for-like
3.1
4.0
3.4
3.6
Net M&A impact (including MJN)
11.9
-
16.9
-
FX impact
(4.8)
(4.1)
(5.7)
(0.3)
Group growth: Net Revenue growth (Actual rates) - continuing operations
9.9
(0.2)
14.0
3.5
Net Revenue Growth: Pro-forma
IFCN
6.0
n/a
6.6
n/a
Rest of Health
n/a
n/a
n/a
n/a
Total Health
3.7
n/a
4.0
n/a
Hygiene Home
n/a
n/a
n/a
n/a
Group growth: Pro-forma
3.4
-
3.8
n/a
Net Revenue - Total Reported
IFCN
2,890
735
2,176
3,022
Rest of Health
4,895
1,233
3,600
5,071
Total Health
7,785
1,968
5,776
8,092
Hygiene Home
4,811
1,228
3,565
4,923
Total Net Revenue
12,596
3,196
9,341
13,015
Operating Profit - Adjusted
Health
2,250
-
n/a
2,419
Hygiene Home
1,116
-
n/a
1,140
Total Operating Profit - Adjusted
3,366
-
n/a
3,559
Operating Margin - Adjusted
Health
28.9
n/a
n/a
29.9
Hygiene Home
23.2
n/a
n/a
23.2
Total Operating Margin - Adjusted
26.7
n/a
n/a
27.3
Net Finance Expense
(301)
n/a
n/a
(264)
Taxation (expense)/benefit
(681)
n/a
n/a
(746)
Non-controlling Interest
(21)
n/a
n/a
(22)
Continuing Operations
Net income - adjusted
2,334
n/a
n/a
2,508
EPS, Group, fully diluted, adjusted (p)
329.9
n/a
n/a
353.7

Disclaimer

Earnings forecasts are produced by the contributing registered investment analysts currently covering RB.

The estimates that are used to compile the consensus are the sole responsibility of the registered investment
analysts. RB uses Vuma to compile the consensus information, and does not endorse or concur with such analyst
information, conclusions or recommendations. RB has not verified any of the information received and none of RB,
its affiliates or any of its or their respective directors, officers and employees make any representation or warranty,
express or implied, as to, or accepts any responsibility for, the accuracy or completeness of the consensus
information. RB shall not be liable (whether in contract, tort or otherwise) for any errors, inaccuracies or omissions in
the content of the information (either at the date of issue of these forecasts, or any other date), or for any action
taken in reliance thereon. RB does not assume any responsibility to update, revise or supplement such information.

The information provided by RB is for information purposes only and is not intended for trading purposes. It should
be noted that forecasts are forward-looking and are therefore subject to risks and uncertainties (including unknown
risks and uncertainties) that may materially affect eventual results.

THE FORECASTS PROVIDED ARE BASED ON A MEAN AVERAGE OF ESTIMATES PROVIDED AND DO NOT
REPRESENT OR REFLECT, AND SHOULD NOT BE DEEMED TO BE, RB'S OPINIONS, ESTIMATES OR
FORECASTS.